Home LiteratureArticle Details
PMID: 16818644 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Acidic extracellular pH promotes experimental metastasis of human melanoma cells in athymic nude mice.

Cancer research ·Vol. 66 ·No. 13 ·2006-07-01 ·Pages 6699-707

Rofstad EK, Mathiesen B, Kindem K, Galappathi K

Abstract

Extracellular pH (pH(e)) is lower in many tumors than in the corresponding normal tissue. The significance of acidic pH(e) in the development of metastatic disease was investigated in the present work. Human melanoma cells (A-07, D-12, and T-22) were cultured in vitro at pH(e) 6.8 or 7.4 (control) before being inoculated into the tail vein of BALB/c nu/nu mice for formation of experimental pulmonary metastases. Cell invasiveness was studied in vitro by using Matrigel invasion chambers and angiogenesis was studied in vivo by using an intradermal assay. Protein secretion was measured by ELISA and immunocapture assays. Cells cultured at acidic pH(e) showed increased secretion of proteinases and proangiogenic factors, enhanced invasive and angiogenic potential, and enhanced potential to develop experimental metastases. Acidity-induced metastasis was inhibited by treatment with the general matrix metalloproteinase (MMP) inhibitor GM6001, the general cysteine proteinase inhibitor E-64, or blocking antibody against vascular endothelial growth factor-A (VEGF-A) or interleukin-8 (IL-8). Our study indicates that acidic pH(e) promotes experimental pulmonary metastasis in A-07, D-12, and T-22 human melanoma cells by a common mechanism involving acidity-induced up-regulation of the proteolytic enzymes MMP-2, MMP-9, cathepsin B, and cathepsin L and acidity-induced up-regulation of the proangiogenic factors VEGF-A and IL-8. One consequence of this observation is that treatment strategies involving deliberate tumor acidification to improve the efficacy of chemotherapy, photodynamic therapy, and hyperthermia should be avoided. Moreover, the possibility that the pH(e) of the primary tumor may be an important prognostic parameter for melanoma patients merits clinical investigation.

MeSH Terms
Angiogenic Proteins/antagonists & inhibitors,immunology Animals Antibodies/pharmacology Extracellular Fluid/metabolism Female Humans Hydrogen-Ion Concentration Lung Neoplasms/blood supply,metabolism,secondary Melanoma/blood supply,metabolism,pathology,secondary Mice Mice, Inbred BALB C Mice, Nude Neovascularization, Pathologic/metabolism,pathology Peptide Hydrolases/immunology,metabolism Protease Inhibitors/pharmacology Transplantation, Heterologous
Chemicals
Angiogenic Proteins Antibodies Protease Inhibitors Peptide Hydrolases
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Rofstad Einar K
Group of Radiation Biology and Tumor Physiology, Department of Radiation Biology, Institute for Cancer Research, The Norwegian Radium Hospital, Montebello, N-0310 Oslo, Norway. e.k.rofstad@labmed.uio.no
Mathiesen Berit
Kindem Kristil
Galappathi Kanthi
Article Info
Journal
Cancer research
Abbr.
Cancer Res
ISSN
0008-5472
Published
2006-07-01
Pages
6699-707
Language
English
Region
United States
NLM ID
2984705R
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com